| Literature DB >> 30054184 |
Eun-Joo Kim1, Young-Eun Kim2, Ja-Hyun Jang3, Eun-Hae Cho3, Duk L Na4, Sang Won Seo4, Na-Yeon Jung5, Jee H Jeong6, Jay C Kwon7, Kee Hyung Park8, Kyung Won Park9, Jae-Hong Lee10, Jee Hoon Roh10, Hee-Jin Kim11, Soo Jin Yoon12, Seong Hye Choi13, Jae-Won Jang14, Chang-Seok Ki15, Seung Hyun Kim16.
Abstract
To identify pathogenic variants in 107 Korean patients with sporadic frontotemporal dementia (FTD), 46 genes related to FTD, amyotrophic lateral sclerosis, and other dementias were screened by next-generation sequencing. Hexanucleotide repeats in C9orf72 gene were also tested by repeat-primed polymerase chain reaction. Next-generation sequencing revealed one known pathogenic variant (c.708+1G>A) in the GRN gene in a patient with behavioral variant FTD (bvFTD). In addition, a novel in-frame deletion (c.2675_2683del) in the CSF1R gene was identified in a patient with bvFTD who had severe bifrontal atrophy with frontal subcortical white matter changes. Novel compound heterozygous variants in the AARS2 gene, c.1040+1G>A and c.636G>A (p.Met212Ile), were found in a patient with bvFTD. Forty-six variants of uncertain significance were detected in other patients. None of the patients had expanded hexanucleotide repeats in C9orf72. These results show that pathogenic variants of known FTD genes are rare in Korean FTD patients but the CSF1R and AARS2 genes should be screened for a genetic diagnosis of FTD or other dementias.Entities:
Keywords: AARS2; CSF1R; Frontotemporal dementia; GRN; Next-generation sequencing
Mesh:
Substances:
Year: 2018 PMID: 30054184 DOI: 10.1016/j.neurobiolaging.2018.06.031
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673